Insider · CIK 0001592481
Gene Salkind
Files at MOBQ (Mobiquity Technologies, Inc.), ZSQR (Coeptis Therapeutics Holdings, Inc.), UPXI (UPEXI, INC.). First filing Jan 9, 2024, latest Nov 21, 2025.
In brief
Gene Salkind files SEC Form 4 as director and 10% owner at UPXI (UPEXI, INC.), and also at ZSQR (Coeptis Therapeutics Holdings, Inc.), MOBQ (Mobiquity Technologies, Inc.). Since Jan 9, 2024, Gene Salkind has reported 5 open-market buys worth $1.3M and 0 open-market sells worth $0, the latest filed on Nov 21, 2025.
After Gene Salkind's past buys, the stock trailed the S&P 500 by a median 68.8% over six months (n = 4), and 0% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $128k of UPXI on Nov 20, 2025, filed Nov 21, 2025, scored 37 (weak). In the last 12 months: 2 buys worth $674k and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
UPXI: UPEXI, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
ZSQR: Coeptis Therapeutics Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | UPXIbuy UPEXI, INC. | $128k 50,000 shares | +30% | - | |
| 40Moderate | UPXIbuy UPEXI, INC. | $546k 200,000 shares | +43% | - | |
| 48Moderate | UPEXI, INC. | $100k 20,243 shares | +6% | - | |
| 59Moderate | UPEXI, INC. | $550k 241,229 shares | +195% | - | |
| 43Moderate | Coeptis Therapeutics Holdings, Inc. | $8,004 11,600 shares | +4% | +1% from low-68% from high |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 3, 2026 | UPXI UPEXI, INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 318,750 | Jul 20, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common stock | +5,700 | $10.56 | $60k | 13,161 | Feb 13, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Common Stock | +3,250 | $0.00 | $0 | 13,161 | Feb 13, 2026 |
| Dec 31, 2025 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common Stock Optionsderivative | +250,000 | - | - | 761,544 | Jan 2, 2026 |
| Nov 20, 2025 | UPXI UPEXI, INC. | POpen-market purchase Common Stockindirect: Trustee | +50,000 | $2.55 | $128k | 218,750 | Nov 21, 2025 |
| Nov 17, 2025 | UPXI UPEXI, INC. | POpen-market purchase Common Stock | +100,000 | $2.65 | $265k | 569,470 | Nov 18, 2025 |
| Nov 17, 2025 | UPXI UPEXI, INC. | POpen-market purchase Common Stockindirect: Trustee | +100,000 | $2.81 | $281k | 168,750 | Nov 18, 2025 |
| Sep 15, 2025 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common Stock | +25,000 | $1.00 | $25k | 8,668,695 | Sep 19, 2025 |
| Sep 15, 2025 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Convertible notesderivative | +100,000 | - | - | 511,544 | Sep 19, 2025 |
| Jul 11, 2025 | UPXI UPEXI, INC. | POpen-market purchase Common Stock | +20,243 | $4.94 | $100k | 385,370 | Jul 30, 2025 |
| Jul 16, 2025 | UPXI UPEXI, INC. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 435,370 | Jul 30, 2025 |
| Jul 16, 2025 | UPXI UPEXI, INC. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 585,370 | Jul 30, 2025 |
| Apr 17, 2025 | UPXI UPEXI, INC. | POpen-market purchase Common Stock | +241,229 | $2.28 | $550k | 365,127 | Apr 25, 2025 |
| Jan 17, 2025 | UPXI UPEXI, INC. | AGrant or award Options to buy common stockderivative | +25,000 | $0.00 | $0 | 25,000 | Apr 25, 2025 |
| Apr 17, 2025 | UPXI UPEXI, INC. | AGrant or award Options to buy common stockderivative | +35,000 | $0.00 | $0 | 35,000 | Apr 25, 2025 |
| Mar 4, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Non-qualified Stock Options (right to buy)derivative | +5,700 | - | - | 8,950 | Mar 6, 2025 |
| Oct 8, 2024 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common Stock Optionsderivative | +250,000 | - | - | 831,544 | Oct 21, 2024 |
| Jan 5, 2024 | ZSQR Coeptis Therapeutics Holdings, Inc. | POpen-market purchase Common Stock | +11,600 | $0.69 | $8,004 | 284,056 | Jan 9, 2024 |
| Dec 15, 2023 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Preferred Stock Series Gderivative | -300,789 | - | - | 3,103,990 | Dec 19, 2023 |
| Dec 15, 2023 | MOBQ Mobiquity Technologies, Inc. | DDisposition to issuer Preferred Stock Series Hderivative | +751,973 | - | - | 7,615,931 | Dec 19, 2023 |
| Dec 19, 2023 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common stock optionsderivative | +100,000 | - | - | 7,715,931 | Dec 19, 2023 |
| Nov 7, 2023 | MOBQ Mobiquity Technologies, Inc. | MOption exercise Common Stockderivative | - | - | - | 96,100 | Nov 9, 2023 |
| Oct 6, 2023 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common Stock | +150,000 | $0.65 | $98k | 448,535 | Nov 9, 2023 |
| Nov 7, 2023 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Preferred Stockderivative | +300,789 | - | - | 3,103,990 | Nov 9, 2023 |
| Oct 6, 2023 | MOBQ Mobiquity Technologies, Inc. | AGrant or award Common Stockderivative | - | - | - | 524,671 | Nov 9, 2023 |
Questions about Gene Salkind
Answered from the filings on this page, as of the latest one.
Is Gene Salkind buying or selling?
In the last 12 months Gene Salkind reported 2 open-market buys worth $674k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $128k of UPXI on Nov 20, 2025. Grants, option exercises and tax withholding are not counted.
How did Gene Salkind's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 68.8% over six months across 4 past buys, with 0% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Gene Salkind file Form 4?
Gene Salkind has filed Form 4 at UPXI (UPEXI, INC.); ZSQR (Coeptis Therapeutics Holdings, Inc.); MOBQ (Mobiquity Technologies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.